Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

BMY 50.28 -5.21 (-9.38%)
price chart
Bristol-Myers Squibb stock sinks 7.2% after it says it won't pursue ...
Bristol-Myers Squibb Co. BMY, -9.21% shares sunk 7.2% in pre-market trade Friday after the company said it wouldn't try for accelerated approval in first-line lung cancer for its combination of Opdivo and Yervoy.
Bristol-Myers Squibb Co. (BMY): Execution Risk Higher - BMO  StreetInsider.com
Bristol-Myers Falls Further Behind Merck in Lung Cancer Race  Bloomberg
Analyst Downgrades: Bristol-Myers Squibb Co, Teva Pharmaceutical Industries ...
Analysts are weighing in on biotech stocks Bristol-Myers Squibb Co (NYSE:BMY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Endo International plc - Ordinary Shares (NASDAQ:ENDP).
Bristol-Myers Squibb Co (NYSE:BMY) Heffx Technical Analysis
During the past 10 bars, there have been 4 white candles and 6 black candles for a net of 2 black candles. During the past 50 bars, there have been 28 white candles and 22 black candles for a net of 6 white candles.
Investors Catching Stocks: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) will report its next earnings on 26-Jan-17. The company reported the earnings of $0.77/Share in the last quarter where the estimated EPS by analysts was $0.65/share.
Bristol-Myers Squibb Company (BMY) Stake Raised by Bartlett & Co. LLC  Sports Perspectives
Bristol-Myers Squibb Co: Bears Will Continue to Ravage BMY Stock  Profit Confidential
Agree To Purchase Bristol-Myers Squibb Co. At $30, Earn 2.7% Using Options
Investors eyeing a purchase of Bristol-Myers Squibb Co. (Symbol: BMY) shares, but cautious about paying the going market price of $58.88/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Notable Stock Analysts Ratings: Bristol-Myers Squibb Company (NYSE:BMY)  News Oracle
Bank of Montreal Can Has $143004000 Position in Bristol-Myers Squibb Co. (BMY)  Sports Perspectives
Bristol-Myers Squibb Co (BMY) Could Benefit From AstraZeneca plc (ADR) (AZN ...
BMO Capital weighed in on AstraZeneca plc (ADR) (NYSE:AZN) recently following the announcement of refined endpoint for Phase III Mystic trial and the delay in immuno-oncology combination data.
AstraZeneca plc (ADR) (AZN) MYSTIC Change Incrementally Positive for Merck ...  Smаrt Stоck Nеws
Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for January 04, 2017
Bristol-Myers Squibb Company ( BMY ) will begin trading ex-dividend on January 04, 2017. A cash dividend payment of $0.39 per share is scheduled to be paid on February 01, 2017.
Bristol-Myers Squibb Co (NYSE:BMY) Agrees To Extend Research With Five Prime ...  Market Exclusive
It Was CheckMate for Bristol-Myers Squibb Company in 2016  Motley Fool
analysts Recommendations: Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) will report its next earnings on 26-Jan-17. The company reported the earnings of $0.77/Share in the last quarter where the estimated EPS by analysts was $0.65/share.
Bristol-Myers Squibb Company (BMY) Shares Bought by BlackRock Japan Co. Ltd  Sports Perspectives
Analyst Research Summary: Bristol-Myers Squibb Company (NYSE:BMY)  The Independent Republic
Jacobs & Co Buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb ...
Investment company Jacobs & Co buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals Inc, Nike Inc, sells Qualcomm Inc, Raytheon Co, The Hain Celestial Group Inc, Viacom Inc, Twitter Inc during the 3-months ...
First Manhattan Co. Acquires 1113 Shares of Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company logo First Manhattan Co. boosted its stake in shares of Bristol-Myers Squibb Company (NYSE:BMY) by 1.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Bristol-Myers Squibb Company (NYSE:BMY) Analyst Estimates  The Independent Republic
Two Stable Stocks: Transgenomic Inc. (NASDAQ:TBIO), Bristol-Myers Squibb ...  FactsReporter